Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hourigan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Letters|January 10, 2022
Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancerAnurag Mishra, David Hourigan, Andrew J Lindsay
BMC Genomics|December 19, 2025
Colocalisation of lanthipeptide production with genetic exchange and defence systems across prokaryote genomesDavid Hourigan, Colin Hill, R Paul Ross
BMC Microbiology|March 28, 2024
Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategyDavid Hourigan, Ewelina Stefanovic, Colin Hill, et al.
Molecular Nutrition & Food Research|October 29, 2025
Streptocyclin BTW is a novel member of a diverse family of circular bacteriocins in the genus StreptococcusFelipe Miceli de Farias, David Hourigan, Paula M O'Connor, et al.
Journal of Bacteriology|October 15, 2024
Discovery and synthesis of leaderless bacteriocins from the ActinomycetotaDavid Hourigan, Felipe Miceli de Farias, Paula M O'Connor, et al.
Mbio|September 10, 2025
Nisin-like biosynthetic gene clusters are widely distributed across microbiomesDavid Hourigan, Des Field, Ellen Murray, et al.
Msystems|May 27, 2026
The Hungate1000 prokaryotic culture collection encodes a wide variety of bacteriocinsDavid Hourigan, Lorraine Draper, Sinead C Leahy, et al.
Frontiers in Microbiology|September 10, 2024
Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by <i>Staphylococcus caledonicus</i>Michelle O'Connor, Paula M O'Connor, David Hourigan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Letters|January 10, 2022
Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancerAnurag Mishra, David Hourigan, Andrew J Lindsay
BMC Genomics|December 19, 2025
Colocalisation of lanthipeptide production with genetic exchange and defence systems across prokaryote genomesDavid Hourigan, Colin Hill, R Paul Ross
BMC Microbiology|March 28, 2024
Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategyDavid Hourigan, Ewelina Stefanovic, Colin Hill, et al.
Molecular Nutrition & Food Research|October 29, 2025
Streptocyclin BTW is a novel member of a diverse family of circular bacteriocins in the genus StreptococcusFelipe Miceli de Farias, David Hourigan, Paula M O'Connor, et al.
Journal of Bacteriology|October 15, 2024
Discovery and synthesis of leaderless bacteriocins from the ActinomycetotaDavid Hourigan, Felipe Miceli de Farias, Paula M O'Connor, et al.
Mbio|September 10, 2025
Nisin-like biosynthetic gene clusters are widely distributed across microbiomesDavid Hourigan, Des Field, Ellen Murray, et al.
Msystems|May 27, 2026
The Hungate1000 prokaryotic culture collection encodes a wide variety of bacteriocinsDavid Hourigan, Lorraine Draper, Sinead C Leahy, et al.
Frontiers in Microbiology|September 10, 2024
Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by <i>Staphylococcus caledonicus</i>Michelle O'Connor, Paula M O'Connor, David Hourigan, et al.
Pageof 1